ARGININEMIA

 

ARGININEMIA

 

DEFINITION:

A disorder of the urea cycle characterized by the accumulation of ammonia resulting in an altered level of consciousness and other neurological manifestations.

EPIDEMIOLOGY:

  • incidence: rare (about 25 cases reported)
  • age of onset:
    • childhood
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: 6q23
      • gene: arginase
    • M = F

PATHOGENESIS:

1. Background

  • arginase is the fifth and final enzyme in the urea cycle
  • a cytosolic enzyme, arginase catalyzes the conversion of arginine to ornithine + urea

2. Genetic Defect

  • genetic defect -> deficiency of arginase -> accumulation of ammonia and arginine
  • ammonia is a neurotoxin affecting the CNS
  • arginine accumulates in the blood, CSF, and urine
  • recurrent episodes of severe hyperammonemia are usually not present in this disorder

CLINICAL FEATURES:

1. Neurological Manifestations

  • asymptomatic for the first few months to years of life
  • insidious onset with presentation in childhood (2-3 years):

1. Loss of Developmental Milestones

1. Gross Motor

  • increased clumsiness
  • spastic quadriplegia (lower > upper limbs) with loss of ambulation eventually

2. Speech and Language

  • eventually loose speech

3. Cognition

  • progressive mental retardation

2. Others

  • choreoathetotic movements
  • seizures + EEG anomalies
  • hepatomegaly

INVESTIGATIONS:

1. Serum

  • venous hyperammonemia
  • normal anion gap; respiratory alkalosis
  • amino acids
    • citrulline between 100-300 uM)
    • elevated arginine (>1 uM)
    • other amino acids are normal

2. Urine

  • elevated arginine, lysine, cystine, ornithine, and orotic acid

3. Diagnosis

  • deficiency of arginase activity in liver samples and RBC lysates (can be obtained from cord samples)

MANAGEMENT:

1. Supportive

  • a chronic progressive disorder and thus must:
    • provide long-term follow-up
    • moniter ammonia levels
    • coordinate a multidisciplinary approach:
      • Paediatrics, Neurology, Dietary, Genetics, Metabolics

 

2. Goals of Therapy

  • asymptomatic control of and avoidance of acute episodes
  • not curative

 

3. Diet

1. Protein Restriction

1. Exogenous

  • Mead Johnson 80056 Formula
    • non-protein containing formula
    • supplement with arginine

2. Endogenous

  • High Caloric Diet
    • use to minimize tissue catabolism and thus the breakdown of endogenous protein

4. Convert Nitrogen to an Excretable Compound

1. Sodium Benzoate

  • conjugate with glycine and excreted as hippuric acid

2. Sodium Phenylacetate

  • conjugate with glutamine and excreted as phenylacetyl-glutamine

3. Dialysis

  • Peritoneal or Hemodialysis

5. Prognosis

  • good prognosis if disorder is treated prospectively from birth
  • progressive neurological manifestations if untreated

 

 

 

Pediatric Database - ARGININEMIA

Pediatric Organization - Pedbase [at] Gmail.com